EUCTR2013-000389-12-GB
Active, not recruiting
Phase 1
ANti-psychotic Drug REduction in primary care for Adults with Learning Disabilities (ANDREA-LD): A Randomised Double-blind Placebo Controlled Trial - ANDREA-LD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Cardiff University
- Enrollment
- 22
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants will be: i. Adult (18 years or over). ii. Have a learning disability as judged by administrative classification (e.g. on practice learning disability register, in receipt of an annual learning disability health check, in receipt of learning disability services) and a score on the Adaptive Behaviour Scale that converts to an estimated IQ of 70 or below using the method described by Moss and Hogg (1997\). iii. Currently prescribed one of two anti\-psychotic drugs, haloperidol or risperidone, for treatment of challenging behaviour.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 310
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range 0
Exclusion Criteria
- •Other than the obverse of the inclusion criteria, participants will be excluded if: i. They have a current diagnosis of psychosis, ii. They have had a known recurrence of psychosis following previous drug reduction in the past 3 years, iii. The clinician responsible for their treatment judges for any other reason that the participation in a drug reduction programme may be counter\-indicated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Terminated
Not Applicable
Does Antipsychotic Dose Reduction in combination with Evidence-Based Intensive Recovery Treatment (EBIRT) Lead to Better Functional Recovery in First Episode Psychosis: A Randomised Controlled TrialFirst Episode PsychosisMental Health - Psychosis and personality disordersMental Health - SchizophreniaPublic Health - Health service researchACTRN12617000870358Orygen, the National Centre of Excellence in Youth Mental Health44
Active, not recruiting
Not Applicable
Deprescribing of antipsychotics of patients with dementia in long term care - an intervention studyF03Unspecified dementiaDRKS00017831Medizinische Fakultät der TU München, Klinik und Poliklinik für Psychiatrie und Psychotherapie32
Active, not recruiting
Not Applicable
Seponering av antipsykotika og antidepressiva hos demente pasienter med APSD i sykehjem - en åpen studie.The included patients are all elderly people with dementia of Alzheimer or vascular type. Their dementia is moderate or severe and they all have Behavioral or Psychological Symptomes (BPSD).MedDRA version: 8.1Level: LLTClassification code 10057678Term: Vascular dementiaEUCTR2006-000287-84-NOSykehuset Innlandet HF24
Completed
Not Applicable
Anti-psychotic drug reduction in primary care for adults with learning disabilitiesearning disabilitiesMental and Behavioural DisordersDevelopmental disorder of scholastic skills, unspecifiedISRCTN38126962Cardiff University (UK)310
Recruiting
Phase 3
Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?NL-OMON55806Erasmus MC, Universitair Medisch Centrum Rotterdam122